businesspress24.com - StockNewsNow.com Publishes New SNNLive Video Interview With M Pharmaceutical Inc.
 

StockNewsNow.com Publishes New SNNLive Video Interview With M Pharmaceutical Inc.

ID: 1386150

(firmenpresse) - LOS ANGELES, CA -- (Marketwired) -- 09/17/15 -- , The Official MicroCap News Source™, today published an SNNLive Video Interview with Matthew Lehman, CEO of M Pharmaceutical Inc. (CSE: MQ) (OTCQB: MPHMF), a clinical-stage company developing technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications, according to the Company''s website (see here: ). The video interview was recorded at the SeeThruEquity Fall MicroCap Investor Conference 2015 in New York City, NY.

Click the following link to watch the SNNLive Video Interview on StockNewsNow.com:



You can follow Stock News Now on , , , , and

Please review important disclosures on our website at:



Formed in early 2015, M Pharmaceutical Inc. is a clinical-stage company developing innovative technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications. The Company has exclusive rights to three technologies: (1) Trimeo capsules, temporary controllable pseudobezoars for non-invasive gastric volume reduction for the treatment of obesity; (2) Trimtec, gastrointestinal neurostimulators implanted laparoscopically for the treatment of obesity and gastroparesis without permanent anatomical modification of the stomach; and (3) eMosquito wearable blood monitor, for automatic and autonomous monitoring of blood glucose by diabetics.
M Pharmaceutical trades on the Canadian Securities Exchange (CSE) under the ticker symbol "MQ" as well as on the OTCQB as "MPHMF" and FWB (Frankfurt Stock Exchange) as "T3F2."

For more information and company description, go to:



is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature user-generated video, SNN-produced video like SNNLive CEO video interviews, as well as research reports, radio interviews, PowerPoint presentations, articles, and their latest news and headlines. Users can engage directly and share the information provided through social media.





Follow the companies YOU want to know more about; read and watch content from YOUR favorite microcap, emerging growth financial experts; register to attend financial conferences of YOUR choosing; find microcap and emerging growth financial professionals that YOU may be looking for -- all here on StockNewsNow.com.



Embedded Video Available:



StockNewsNow.com


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Franklin Resources, Inc. Announces Quarterly Dividend
Cambridge Global Payments Earns Ranking on 2015 PROFIT 500 for Third Consecutive Year
Bereitgestellt von Benutzer: Marketwired
Datum: 17.09.2015 - 06:30 Uhr
Sprache: Deutsch
News-ID 1386150
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

LOS ANGELES, CA


Phone:

Kategorie:

Investment Services & Trading


Anmerkungen:


Diese Pressemitteilung wurde bisher 158 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"StockNewsNow.com Publishes New SNNLive Video Interview With M Pharmaceutical Inc.
"
steht unter der journalistisch-redaktionellen Verantwortung von

SNN Incorporated (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von SNN Incorporated



 

Who is online

All members: 10 566
Register today: 1
Register yesterday: 0
Members online: 0
Guests online: 108


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.